Filing Details

Accession Number:
0001493152-23-032372
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-09-12 16:58:37
Reporting Period:
2023-09-08
Accepted Time:
2023-09-12 16:58:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1873835 Immix Biopharma Inc. IMMX Pharmaceutical Preparations (2834) 454869378
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1895035 Jason Hsu 11400 West Olympic Blvd.
Suite 200
Los Angeles CA 90064
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-09-08 10,000 $2.53 685,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,915,913 Indirect See Footnote
Common Stock 50,000 Indirect See Footnote
Footnotes
  1. This figure is the weighted average sales price of multiple trades ranging from $2.51 to $2.559 per share. The Reporting Person undertakes to provide the staff of the Securities and Exchange Commission, Immix Biopharma, Inc. or any security holder of Immix Biopharma, Inc. full information about the number of shares sold at each separate price upon request.
  2. Jason Hsu is the Sole Member of VERITAS LIBERABIT VOS, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.
  3. Jason Hsu is the Sole Member of Signature Collection Properties, LLC and in such capacity has the right to vote and dispose of the securities held by such entity.